s 14297 has been researched along with iodosulpride in 1 studies
| Studies (s 14297) | Trials (s 14297) | Recent Studies (post-2010) (s 14297) | Studies (iodosulpride) | Trials (iodosulpride) | Recent Studies (post-2010) (iodosulpride) |
|---|---|---|---|---|---|
| 15 | 0 | 0 | 39 | 0 | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Audinot, V; Jacques, V; Millan, MJ; Newman-Tancredi, A; Peglion, JL | 1 |
1 other study(ies) available for s 14297 and iodosulpride
| Article | Year |
|---|---|
[3H](+)S 14297: a novel, selective radioligand at cloned human dopamine D3 receptors.
Topics: 2-Naphthylamine; Animals; Binding, Competitive; CHO Cells; Cricetinae; Dopamine Agents; Furans; Humans; Ligands; Receptors, Dopamine D2; Receptors, Dopamine D3; Sulpiride; Transfection; Tritium | 1995 |